125 related articles for article (PubMed ID: 38429079)
1. Trajectories of physical well-being among adults with acute myeloid leukemia.
Jensen-Battaglia M; Sohn MB; Consagra W; Wang Y; Zhang Z; LoCastro M; Davis J; Buettner K; Mortaz S; El-Jawahri AR; Loh KP
Blood Adv; 2024 Jun; 8(11):2612-2621. PubMed ID: 38429079
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial.
El-Jawahri A; LeBlanc TW; Kavanaugh A; Webb JA; Jackson VA; Campbell TC; O'Connor N; Luger SM; Gafford E; Gustin J; Bhatnagar B; Walker AR; Fathi AT; Brunner AM; Hobbs GS; Nicholson S; Davis D; Addis H; Vaughn D; Horick N; Greer JA; Temel JS
JAMA Oncol; 2021 Feb; 7(2):238-245. PubMed ID: 33331857
[TBL] [Abstract][Full Text] [Related]
3. Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial.
El-Jawahri A; Luskin MR; Greer JA; Traeger L; Lavoie M; Vaughn DM; Andrews S; Yang D; Boateng KY; Newcomb RA; Ufere NN; Fathi AT; Hobbs G; Brunner A; Abel GA; Stone RM; DeAngelo DJ; Wadleigh M; Temel JS
Cancer; 2023 Apr; 129(7):1075-1084. PubMed ID: 36655338
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported outcomes predict overall survival in older patients with acute myeloid leukemia.
Peipert JD; Efficace F; Pierson R; Loefgren C; Cella D; He J
J Geriatr Oncol; 2022 Sep; 13(7):935-939. PubMed ID: 34521609
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal changes in cognitive and physical function and health-related quality of life in older adults with acute myeloid leukemia.
Bhatt VR; Wichman C; Koll TT; Fisher AL; Wildes TM; Berger A; Armitage JO; Holstein SA; Maness LJ; Gundabolu K
J Geriatr Oncol; 2024 Jan; 15(1):101676. PubMed ID: 38000343
[TBL] [Abstract][Full Text] [Related]
6. Do quality of life or physical function at diagnosis predict short-term outcomes during intensive chemotherapy in AML?
Timilshina N; Breunis H; Brandwein JM; Minden MD; Gupta V; O'Neill S; Tomlinson GA; Buckstein R; Li M; Alibhai SMH
Ann Oncol; 2014 Apr; 25(4):883-888. PubMed ID: 24667720
[TBL] [Abstract][Full Text] [Related]
7. Patient preferences, regret, and health-related quality of life among older adults with acute myeloid leukemia: A pilot longitudinal study.
LoCastro M; Wang Y; Sanapala C; Jensen-Battaglia M; Wittink M; Norton S; Klepin HD; Richardson DR; Mendler JH; Liesveld J; Huselton E; Loh KP
J Geriatr Oncol; 2023 Jun; 14(5):101529. PubMed ID: 37244139
[TBL] [Abstract][Full Text] [Related]
8. Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes.
Dharmani C; Wang E; Tu N; Fofah O; Cueto J; Salas M; Kamel YM
Future Oncol; 2023 Aug; 19(24):1677-1693. PubMed ID: 37345543
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age.
Alibhai SM; Breunis H; Timilshina N; Brignardello-Petersen R; Tomlinson G; Mohamedali H; Gupta V; Minden MD; Li M; Buckstein R; Brandwein JM
J Geriatr Oncol; 2015 Jul; 6(4):262-71. PubMed ID: 25944029
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database.
Dharmani C; Wang E; Tu N; Salas M; Kamel YM
Future Oncol; 2023 Jan; 19(2):159-171. PubMed ID: 36912693
[TBL] [Abstract][Full Text] [Related]
11. Experiences of treatment decision-making among older newly diagnosed adults with acute myeloid leukemia: a qualitative descriptive study.
Richardson DR; Mhina CJ; Teal R; Cole AC; Adapa K; Bryant AL; Crossnohere N; Wheeler SC; Bridges JFP; Wood WA
Support Care Cancer; 2024 Feb; 32(3):197. PubMed ID: 38416230
[TBL] [Abstract][Full Text] [Related]
12. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
Meyers J; Yu Y; Kaye JA; Davis KL
Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
[TBL] [Abstract][Full Text] [Related]
13. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy.
El-Jawahri A; Abel GA; Traeger L; Waldman L; Markovitz N; VanDusen H; Fathi A; Steensma DP; LeBlanc TW; Horick NK; DeAngelo DJ; Wadleigh M; Hobbs G; Foster J; Brunner AM; Amrein P; Stone RM; Temel JS; Greer JA
Leukemia; 2019 Oct; 33(10):2393-2402. PubMed ID: 30923318
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Functional Assessment of Cancer Therapy-Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapy.
Peipert JD; Yount SE; Efficace F; Loefgren C; Pierson R; He J; Cella D
Cancer; 2020 Aug; 126(15):3542-3551. PubMed ID: 32463931
[TBL] [Abstract][Full Text] [Related]
16. Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia.
Sorror ML; Storer BE; Fathi AT; Brunner A; Gerds AT; Sekeres MA; Mukherjee S; Medeiros BC; Wang ES; Vachhani P; Shami PJ; Peña E; Elsawy M; Adekola K; Luger S; Baer MR; Rizzieri D; Wildes TM; Koprivnikar J; Smith J; Garrison M; Kojouri K; Leisenring W; Onstad L; Nyland JE; Becker PS; McCune JS; Lee SJ; Sandmaier BM; Appelbaum FR; Estey EH
Blood; 2021 Aug; 138(5):387-400. PubMed ID: 34351368
[TBL] [Abstract][Full Text] [Related]
17. Assessment of an embedded primary care-derived electronic health record (EHR) frailty index (eFI) in older adults with acute myeloid leukemia.
Cheng JJ; Tooze JA; Callahan KE; Pajewski NM; Pardee TS; Reed DR; Klepin HD
J Geriatr Oncol; 2023 Sep; 14(7):101509. PubMed ID: 37454532
[TBL] [Abstract][Full Text] [Related]
18. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
19. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY
Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301
[TBL] [Abstract][Full Text] [Related]
20. A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.
Alymara V; Tzouvara E; Vartholomatos G; Chaidos A; Tsiara S; Bourantas KL
J Exp Clin Cancer Res; 2004 Sep; 23(3):447-54. PubMed ID: 15595635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
